Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Praxis Precision Medicines, Inc. (PRAX) had Operating Cash Flow per Share of $-11.07 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-303.27M |
|
-- |
|
-- |
|
$326.20M |
|
$-326.20M |
|
$22.93M |
|
$-303.27M |
|
$-303.27M |
|
$-303.27M |
|
$-303.27M |
|
$-303.27M |
|
$-303.27M |
|
$-326.20M |
|
$-329.65M |
|
22.50M |
|
22.50M |
|
$-13.48 |
|
$-13.48 |
|
| Balance Sheet Financials | |
$610.91M |
|
$0.15M |
|
$327.00M |
|
$937.91M |
|
$59.77M |
|
-- |
|
-- |
|
$59.77M |
|
$878.14M |
|
$878.14M |
|
$878.14M |
|
25.20M |
|
| Cash Flow Statement Financials | |
$-249.07M |
|
$-311.15M |
|
$702.17M |
|
$215.79M |
|
$357.75M |
|
$141.96M |
|
$33.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-249.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.54% |
|
-34.54% |
|
-32.33% |
|
-34.54% |
|
$34.85 |
|
$-11.07 |
|
|
Operating Cash Flow per Share |
$-11.07 |